GO:0032808 lacrimal gland development: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032808 (lacrimal gland development) describes the progression of the lacrimal gland from formation to mature structure, producing secretions that lubricate and protect the cornea.
• Lacrimal gland development depends on reciprocal epithelial-mesenchymal signaling, with FGF10, BMP7, and Wnt pathways among the best-characterized drivers.
• Human pluripotent stem cells can be directed to form 3D lacrimal gland organoids that recapitulate developmental programs, enabling disease modeling and drug discovery.
• Defective lacrimal gland development or regeneration contributes to dry eye disease, including Sjogren's syndrome-related keratoconjunctivitis sicca.
• Organoid platforms now allow high-throughput screening of compounds that promote lacrimal gland development and function.
• CRISPR-based knockout, knock-in, and overexpression models are essential for testing causal roles of candidate genes in lacrimal gland development.
Description
The lacrimal gland is the primary source of the aqueous layer of the tear film, and its proper development is required for ocular surface health. The Gene Ontology term GO:0032808, lacrimal gland development, captures the biological process by which this organ progresses from its initial formation to a mature, functional structure that produces secretions to lubricate and protect the cornea. Understanding this process is central to developmental biology and to regenerative approaches for lacrimal gland dysfunction. Research over the past decade has identified conserved signaling interactions that govern lacrimal gland specification, budding, and differentiation. These include epithelial-mesenchymal crosstalk involving fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) signals, as well as Wnt and other pathways. More recently, human pluripotent stem cell-derived 3D lacrimal gland organoids have provided a tractable system to study these events in vitro and to model disease. Because loss of lacrimal gland function leads to dry eye disease and related ocular surface pathologies, there is intense interest in defining the molecular players that drive development and regeneration. This article synthesizes the current understanding of lacrimal gland development, highlighting key genes, regulatory mechanisms, disease links, and experimental models including CRISPR-based approaches.
lacrimal gland development At A Glance
| GO ID | GO:0032808 |
|---|---|
| GO term | lacrimal gland development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of the lacrimal gland from formation to mature structure, enabling secretion that lubricates and protects the cornea |
| Related processes | Epithelial-mesenchymal signaling, branching morphogenesis, secretory differentiation |
| Disease relevance | Dry eye disease, Sjogren's syndrome-related keratoconjunctivitis sicca |
| Model systems | Human pluripotent stem cell-derived 3D organoids, animal models |
What Is GO:0032808?
GO:0032808 (lacrimal gland development) is the biological process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye. This term encompasses the cellular and molecular events that lead to a functional secretory organ, including inductive signaling, branching morphogenesis, and differentiation of secretory cell types.
Why Is lacrimal gland development Important in Cell Biology?
Lacrimal gland development is essential for establishing the ocular surface defense system, and its disruption leads to tear film instability, dry eye disease, and corneal damage. Because the lacrimal gland has limited regenerative capacity in adults, understanding developmental mechanisms offers a roadmap for regenerative medicine and cell-based therapies. Moreover, human pluripotent stem cell-derived lacrimal gland organoids now enable disease modeling and drug discovery, making the study of GO:0032808 directly translational.
• Provides the developmental basis for the aqueous tear film that protects the cornea.
• Dysregulation is linked to dry eye disease and Sjogren's syndrome-related ocular surface damage.
• Informs regenerative strategies for lacrimal gland repair and replacement.
• Enables human pluripotent stem cell-based organoid models for developmental studies.
• Supports high-throughput drug discovery for dry eye disease.
• Helps identify conserved signaling pathways such as FGF, BMP, and Wnt in gland morphogenesis.
• Facilitates systematic reviews and molecular profiling of lacrimal gland organoids.
• Guides CRISPR-based functional genomics of candidate developmental genes.
What Happens During lacrimal gland development?
Specification and induction of the lacrimal gland placode
In simple terms: The first step is telling a patch of surface cells to become a gland.
Lacrimal gland development begins with inductive signals from the surrounding mesenchyme that specify the lacrimal gland placode in the ocular surface epithelium. FGF10 and BMP7 are among the key mesenchymal signals that promote epithelial proliferation and gland fate. These interactions are conserved across species and are required for subsequent budding and morphogenesis.
Branching morphogenesis and epithelial budding
In simple terms: The gland grows by splitting into branches, like a tree.
After specification, the lacrimal gland epithelium undergoes branching morphogenesis, forming lobules and ducts that increase secretory surface area. This process requires coordinated cell proliferation, migration, and extracellular matrix remodeling. FGF signaling, particularly FGF10, is a major driver of branching in many exocrine glands, including the lacrimal gland.
Secretory cell differentiation and maturation
In simple terms: The gland cells mature to produce tears.
As the gland matures, epithelial cells differentiate into acinar and ductal cells capable of producing and secreting tear fluid components. This differentiation is accompanied by expression of secretory proteins and ion channels that regulate fluid secretion. The mature lacrimal gland structure is essential for maintaining tear film homeostasis.
Mesenchymal-epithelial crosstalk and extracellular matrix
In simple terms: Cells talk to each other and to the scaffold around them to build the gland.
Reciprocal signaling between epithelium and mesenchyme is critical throughout lacrimal gland development. The extracellular matrix provides structural support and modulates growth factor availability. Disruption of these interactions impairs gland formation and function.
Organoid modeling of lacrimal gland development
In simple terms: Scientists can grow miniature glands in a dish to study development.
Human pluripotent stem cells can be differentiated into 3D lacrimal gland organoids that recapitulate key developmental steps. These organoids have been used to study signaling requirements and to screen for compounds that enhance gland function. Systematic reviews have summarized the molecular profiling and translational potential of these organoid platforms.
Key Genes Involved in GO:0032808 lacrimal gland development
The following genes and proteins have been implicated in lacrimal gland development based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF10 | Mesenchymal signal promoting epithelial proliferation and budding | Knockout models show impaired gland morphogenesis |
| BMP7 | Inductive signal for lacrimal gland specification | Conditional knockout to test developmental requirement |
| Wnt | Regulates branching and differentiation | Reporter models and pathway modulators |
| Shh | May influence gland patterning | Conditional knockout and overexpression |
| Pax6 | Transcription factor in ocular surface development | Mutant models for eye and gland defects |
| Sox2 | Stem/progenitor cell maintenance | Lineage tracing and knockout |
| E-cadherin | Epithelial cell adhesion during morphogenesis | Knockout and rescue experiments |
| Fibronectin | Extracellular matrix component | Matrix perturbation studies |
| Laminin | Basement membrane support | Knockout and organoid culture |
| AQP5 | Water channel in secretory cells | Functional assays in organoids |
| MUC5B | Mucin secretion | Expression profiling |
| Lacritin | Tear protein promoting epithelial health | Overexpression and knockdown |
| EGFR | Growth factor receptor signaling | Inhibitor and knockout studies |
| FGFR2 | Receptor for FGF10 | Conditional knockout |
| BMPR1A | Receptor for BMP7 | Conditional knockout |
| TP63 | Epithelial stem cell transcription factor | Lineage tracing |
| Ki67 | Proliferation marker | Immunostaining in developing gland |
| CD44 | Cell surface marker in progenitors | Flow cytometry and organoid sorting |
How Is lacrimal gland development Regulated?
Lacrimal gland development is regulated by a network of secreted growth factors and transcription factors that control proliferation, differentiation, and morphogenesis. FGF10 signaling through FGFR2b is a major driver of epithelial budding, while BMP7 and Wnt pathways modulate specification and branching. Mesenchymal-epithelial crosstalk ensures coordinated growth and differentiation. In vitro organoid systems have shown that modulation of these pathways can enhance or impair gland formation. Additionally, inflammatory cytokines associated with Sjogren's syndrome can disrupt gland function, highlighting the interplay between developmental and immune signaling.
lacrimal gland development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF10 | Lacrimal gland hypoplasia/aplasia | Knockout mouse and organoid culture |
| BMP7 | Defective gland specification | Conditional knockout |
| AQP5 | Impaired tear secretion | Knockout and overexpression in organoids |
| Lacritin | Dry eye disease | Overexpression and knockdown |
| TP63 | Epithelial stem cell dysfunction | Lineage tracing and knockout |
Dry eye disease and lacrimal gland dysfunction
Dry eye disease is a multifactorial disorder often characterized by reduced tear production due to lacrimal gland dysfunction. Defects in lacrimal gland development or regeneration can contribute to aqueous-deficient dry eye. Organoid models derived from human pluripotent stem cells are being used to study disease mechanisms and test therapeutics.
Sjogren's syndrome-related keratoconjunctivitis sicca
Sjogren's syndrome is an autoimmune disease that targets lacrimal and salivary glands, leading to severe dry eye. Chronic inflammation and immune-mediated damage impair gland function. New therapeutic approaches, such as ROS-responsive microneedle patches, aim to deliver drugs to the peri-lacrimal gland area for long-acting relief.
Regenerative medicine for lacrimal gland diseases
Cell technologies and regenerative strategies are being developed to restore lacrimal gland function. Human pluripotent stem cell-derived organoids offer a renewable source of glandular cells for transplantation and drug screening. Systematic reviews highlight the translational potential of these approaches for dry eye disease.
From lacrimal gland development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is FGF10 required for lacrimal gland budding? | FGF10 knockout mouse or organoid |
| Does a point mutation in FGFR2b alter signaling? | Knock-in point mutation in cell line |
| Can overexpression of BMP7 expand gland progenitors? | Overexpression in human organoids |
| What is the role of AQP5 in tear secretion? | AQP5 knockout and rescue |
| Can CRISPR screen identify novel developmental regulators? | Pooled CRISPR library in organoids |
| Does tagged knock-in of Pax6 reveal lineage? | Tagged knock-in reporter |
How to Study the lacrimal gland development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 3D organoid culture | Self-organization and differentiation | Modeling development and disease |
| RNA-seq | Transcriptome changes | Identifying developmental pathways |
| Proteomics | Protein expression and secretion | Discovering biomarkers |
| Immunofluorescence | Protein localization and morphology | Validating gene function |
| CRISPR screening | Gene essentiality and regulators | Unbiased discovery of developmental genes |
| Calcium imaging | Ion channel activity | Testing secretagogues |
| High-throughput drug screening | Compound effects on organoids | Drug discovery for dry eye |
Organoid culture and differentiation
Human pluripotent stem cells can be differentiated into 3D lacrimal gland organoids that self-organize and recapitulate developmental stages. These organoids can be passaged and used for high-throughput drug screening. Systematic reviews have standardized protocols for organoid generation and characterization.
Transcriptomic and proteomic profiling
RNA sequencing of developing lacrimal glands and organoids reveals dynamic gene expression programs. Proteomics can identify secreted factors and cell surface markers. Single-cell RNA sequencing has been used to map cell types in lacrimal gland organoids.
Imaging and lineage tracing
Confocal and light-sheet microscopy allow visualization of branching morphogenesis in real time. Lineage tracing using Cre-lox systems can track progenitor cells during development. Immunostaining for markers such as Ki67 and E-cadherin provides spatial information.
Functional assays for secretion
Tear secretion can be assessed in organoids by measuring fluid output or protein secretion. Calcium imaging and patch clamp can evaluate ion channel activity. These assays are used to test drugs that modulate gland function.
How CRISPR Can Be Used to Study GO:0032808 lacrimal gland development
Knockout
CRISPR knockout of candidate genes such as FGF10 or BMP7 in organoids can test their requirement for lacrimal gland development. Knockout models help distinguish essential from redundant pathways.
Point Mutation
Point mutations in receptors like FGFR2b can be introduced to mimic human variants and assess signaling alterations. These models are useful for studying subtle developmental defects.
Knock-in
Knock-in of fluorescent reporters or tags into endogenous loci such as Pax6 enables lineage tracing and protein localization. This approach provides physiological expression control.
Overexpression
Overexpression of growth factors like BMP7 or Wnt can expand progenitor pools and enhance organoid formation. Overexpression models help identify sufficiency of a gene for developmental processes.
How EDITGENE Supports lacrimal gland development Research
Researchers studying lacrimal gland development-related genes often need to determine whether a candidate gene is causally involved in gland formation, maturation, or function. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies in relevant cell models and organoids.
Contact EDITGENE today to design your custom CRISPR model for lacrimal gland development research.
Frequently Asked Questions About lacrimal gland development
What is lacrimal gland development?
Lacrimal gland development (GO:0032808) is the biological process by which the lacrimal gland progresses from formation to a mature structure that produces secretions to lubricate and protect the cornea.
What genes are involved in lacrimal gland development?
Key genes include FGF10, BMP7, Wnt, Pax6, Sox2, and AQP5, among others, which regulate specification, branching, and differentiation.
What signaling pathways control lacrimal gland development?
FGF, BMP, and Wnt signaling pathways are major regulators of lacrimal gland specification and morphogenesis.
How can I study lacrimal gland development in the lab?
Human pluripotent stem cell-derived 3D organoids, animal models, and CRISPR-based gene editing are commonly used.
What diseases are linked to lacrimal gland development?
Dry eye disease and Sjogren's syndrome-related keratoconjunctivitis sicca are associated with lacrimal gland dysfunction.
Can CRISPR be used to study lacrimal gland development?
Yes, CRISPR knockout, knock-in, and overexpression models enable functional testing of candidate genes in organoids and cell lines.
What are lacrimal gland organoids?
Lacrimal gland organoids are 3D structures derived from stem cells that recapitulate key aspects of gland development and function.
How does FGF10 affect lacrimal gland development?
FGF10 is a mesenchymal signal that promotes epithelial proliferation and budding during lacrimal gland morphogenesis.
What is the role of BMP7 in lacrimal gland development?
BMP7 acts as an inductive signal for lacrimal gland specification and branching.
Where can I find CRISPR services for lacrimal gland research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services for lacrimal gland development studies.
Conclusion
GO:0032808 (lacrimal gland development) encompasses the signaling and morphogenetic events that build a functional tear-secreting organ. Understanding these processes is critical for addressing dry eye disease and for advancing regenerative therapies. CRISPR-based models and human organoid platforms now provide powerful tools to dissect the genetic control of lacrimal gland development and to translate these findings into clinical applications.
References
- 1. Garg A et al.. 2017. Lacrimal gland development: From signaling interactions to regenerative medicine.. Dev Dyn 246(12):970-980 PMID: 28710815
- 2. Yao Y et al.. 2017. The lacrimal gland: development, wound repair and regeneration.. Biotechnol Lett 39(7):939-949 PMID: 28353146
- 3. Rodboon T et al.. 2022. Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease.. SLAS Discov 27(3):151-158 PMID: 35058190
- 4. Abdal Dayem A et al.. 2025. Advances in lacrimal gland organoid development: Techniques and therapeutic applications.. Biomed Pharmacother 183:117870 PMID: 39870025
- 5. Siddiqui MG et al.. 2026. Lacrimal gland organoids: A systematic review on development, characterization, molecular profiling and translational potential in dry eye disease.. Exp Eye Res 267:110956 PMID: 41785988
- 6. Mu J et al.. 2025. ROS-Responsive Microneedle Patches Enable Peri-Lacrimal Gland Therapeutic Administration for Long-Acting Therapy of Sjögren's Syndrome-Related Dry Eye.. Adv Sci (Weinh) 12(16):e2409562 PMID: 39792610
- 7. Safonova TN et al.. 2024. [Cell technologies as a basis for the development of regenerative principles for the treatment of lacrimal gland diseases].. Vestn Oftalmol 140(2. Vyp. 2):158-165 PMID: 38739146
- 8. Hayashi R et al.. 2022. Generation of 3D lacrimal gland organoids from human pluripotent stem cells.. Nature 605(7908):126-131 PMID: 35444274
